The Lagos State Attorney-General, Lawal Pedro, has thrown the full weight of the state’s legal machinery against Eurapharma Care Services. The hospital is fighting to stop the coroner’s inquest into the death of Nkanu Adichie-Esege, the 21-month-old son of author Chimamanda Ngozi Adichie. Pedro’s preliminary objection, filed on June 5, 2026, calls the hospital’s judicial review application incompetent, premature and an abuse of court process.

The objection lands in a courtroom already crowded with legal firepower. Eurapharma secured an interim order from Justice A.O. Opesanwo on May 26, 2026. The order temporarily stayed the coroner’s proceedings pending the determination of the hospital’s substantive suit. Eurapharma wants the High Court to quash the coroner’s decisions and prohibit further investigation. The hospital argues that the cremation of the child’s body before the inquest began deprived the coroner of jurisdiction. It also claims the coroner’s directive to call witnesses first breaches fair hearing principles.

The Lagos State legal team dismantles these arguments with statutory precision. Pedro, alongside the Chief Coroner and the presiding coroner, invokes the Coroners System Law of Lagos State. Section 21 of the law explicitly empowers a coroner to conduct an inquest even when the body is unavailable or destroyed. The respondents cite this provision to reject Eurapharma’s cremation claim as legally irrelevant. They also point out that no formal evidence regarding the cremation or the absence of an autopsy report has been presented before the coroner’s court. The hospital’s judicial review application, they argue, is built on speculation rather than established facts.

The respondents further defend the coroner’s procedural directive. The coroner ordered Eurapharma to call witnesses first, a move the hospital describes as a breach of fair hearing. The Lagos AG counters with Supreme Court precedents, including Gyang v Commissioner of Police and Yusuf v State. These cases establish that fair hearing requires only an adequate opportunity for parties to present their case. The respondents argue that Eurapharma has not been denied this opportunity. The hospital can still present evidence and cross-examine witnesses during the inquest.

The legal battle reveals a deeper institutional tension. Eurapharma’s attempt to halt the inquest through judicial review is seen by the state as an effort to bypass statutory procedures. The Coroners System Law grants coroners exclusive authority to investigate suspicious deaths. The respondents argue that the hospital’s application undermines this authority and disrupts the legal framework governing death investigations. The adjournment of the matter to September 28, 2026, prolongs the uncertainty for the Adichie-Esege family. It also sets the stage for a high-stakes legal showdown that could redefine the boundaries of coroner jurisdiction in Lagos State.

The case has exposed a critical gap in Nigeria’s medico-legal infrastructure. The absence of a formal autopsy report before cremation raises questions about the standard operating procedures in private hospitals. Lagos State’s Coroners System Law mandates inquests for suspicious deaths, but the law’s effectiveness hinges on timely forensic evidence. The alleged premature cremation of Nkanu Adichie-Esege’s body suggests a systemic failure to preserve evidence. This gap leaves families vulnerable to prolonged legal battles and denies them closure. The Lagos State government’s opposition to Eurapharma’s suit may be legally sound, but it also highlights the need for stricter enforcement of forensic protocols in private healthcare facilities.

The judicial review application has also spotlighted the power dynamics between private hospitals and state institutions. Eurapharma’s legal strategy appears designed to shift the narrative from medical negligence to procedural irregularities. By challenging the coroner’s jurisdiction and fair hearing compliance, the hospital seeks to divert attention from the circumstances surrounding the child’s death. The Lagos AG’s objection frames this strategy as an attempt to manipulate the legal process. The outcome of this case could set a precedent for how private hospitals engage with state-led investigations. It may also influence public trust in the coroner system, particularly in high-profile cases involving influential families.

The Adichie-Esege family’s ordeal underscores the emotional toll of Nigeria’s slow legal processes. The inquest into Nkanu’s death began in January 2026, yet the case remains unresolved six months later. The interim order halting the inquest adds another layer of delay. For a family already grappling with loss, the legal limbo compounds their grief. The Lagos State government’s opposition to Eurapharma’s suit, while legally justified, prolongs their wait for answers. The case also raises broader questions about the efficiency of Nigeria’s judicial system. High-profile cases often attract public scrutiny, but the delays and procedural complexities affect ordinary citizens just as severely. The Adichie-Esege case may serve as a catalyst for reforms aimed at expediting coroner inquests and reducing unnecessary legal obstacles.

The legal battle has drawn attention to the role of the media in shaping public perception. Chimamanda Ngozi Adichie’s global stature ensures that the case receives extensive coverage. This visibility amplifies the pressure on all parties involved. The Lagos State government’s robust defense of the coroner’s authority may be an attempt to demonstrate its commitment to transparency. Conversely, Eurapharma’s legal maneuvers risk being perceived as an effort to evade accountability. The media’s portrayal of the case could influence public opinion and, ultimately, the court’s decision. The case highlights the delicate balance between legal proceedings and public interest, particularly in matters involving prominent figures.